Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjunctive Aflibercept Ahmed Glaucoma Valve (AAA) Study
NCT07891182Phase 2Not yet recruiting
- Sponsor
- University of Miami
- Start
- Dec 2026
- Primary completion
- Jun 2028
- Countries
- 1
01
Overview
A Phase 2 trial of aflibercept in Glaucoma, sponsored by University of Miami. Planned start Dec 2026; status: not yet recruiting.
02
Drugs
aflibercept
03
Conditions
Glaucoma
Beyond the preview
Go deeper on NCT07891182.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07891182.